Dehydroabietic Acid Is a Novel Survivin Inhibitor for Gastric Cancer
Gastric cancer is a malignant tumor with a high incidence and mortality rate worldwide. Nevertheless, anticancer drugs that can be used for gastric cancer treatment are limited. Therefore, it is important to develop targeted anticancer drugs for the treatment of gastric cancer. Dehydroabietic acid (...
Main Authors: | Won-Jin Kim, Woong Kim, Jang-Mi Bae, Jungsoo Gim, Seok-Jun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Plants |
Subjects: | |
Online Access: | https://www.mdpi.com/2223-7747/10/6/1047 |
Similar Items
-
Bacterial degradation of methyl dehydroabietate
by: Carter, Burl C.
Published: (1968) -
A study of some substitution reactions of dehydroabietic acid
by: Sisco, William Everett
Published: (2010) -
Dehydroabietic Acid Microencapsulation Potential as Biofilm-Mediated Infections Treatment
by: Iris Neto, et al.
Published: (2021-06-01) -
Synthesis and Antiproliferative Activity of Some Novel Triazole Derivatives from Dehydroabietic Acid
by: Mariano Walter Pertino, et al.
Published: (2014-02-01) -
Dehydroabietic Acid Suppresses Inflammatory Response Via Suppression of Src-, Syk-, and TAK1-Mediated Pathways
by: Eunji Kim, et al.
Published: (2019-03-01)